KA
ZBH icon

KLCM Advisors’s Zimmer Biomet ZBH Stock Holding History

KLCM Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
125,568
-2,682
-2% -$235K 0.85% 26
2026
Q1 		$11.6M Sell
128,250
-2,891
-2% -$265K 0.98% 28
2025
Q4 		$11.8M Buy
131,141
+58,427
+80% +$5.54M 1.01% 28
2025
Q3 		$7.16M Sell
72,714
-280
-0.4% -$27.7K 0.71% 33
2025
Q2 		$6.66M Sell
72,994
-1,907
-3% -$184K 0.71% 34
2025
Q1 		$8.48M Buy
74,901
+818
+1% +$87.5K 0.99% 31
2024
Q4 		$7.83M Buy
+74,083
New +$7.95M 0.91% 31

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

KLCM Advisors's ZBH Position: Q2 2026 in Review

KLCM Advisors reduced its Zimmer Biomet (ZBH) stake by 2.1% in Q2 2026, selling an estimated $235K and leaving 125,568 shares worth $10.8M. The position accounts for 0.85% of the portfolio, ranked #26.

KLCM Advisors first reported a position in ZBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.8M in Q4 2025. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • KLCM Advisors held 125,568 shares of Zimmer Biomet worth $10.8M as of Q2 2026.
  • KLCM Advisors sold 2,682 Zimmer Biomet shares in Q2 2026, an estimated $235K.
  • Zimmer Biomet made up 0.85% of KLCM Advisors's portfolio in Q2 2026, its #26 holding.
  • KLCM Advisors first reported a position in Zimmer Biomet in Q4 2024 and has held it in 7 quarters since.
  • KLCM Advisors's Zimmer Biomet position peaked at $11.8M in Q4 2025.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.